[The physiopathology of inflammatory nasal mucosa lesions. The significance of the galenic type of local therapeutic agents].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002923:Cilia / Q000502:physiology; D005069:Evaluation Studies as Topic; D005260:Female; D005782:Gels; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008747:Methylcellulose; D008875:Middle Aged; D009093:Mucus / Q000502:physiology; D009297:Nasal Mucosa / Q000502:physiology; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014677:Pharmaceutical Vehicles; D010656:Phenylephrine / Q000008:administration & dosage / Q000627:therapeutic use*; D012220:Rhinitis / Q000188:drug therapy* / Q000503:physiopathology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D005782:Gels; D006634:Histamine H1 Antagonists; D014677:Pharmaceutical Vehicles; D010656:Phenylephrine; D008747:Methylcellulose; D009355:Neomycin
Zur Pathophysiologie entzündlicher Nasenschleimhautaffektionen. Die Bedeutung der galenischen Form lokaler Therapeutika.